Cas:23814-14-4 2-oxo-1,3-dihydrobenzimidazole-5-carboxylic acid manufacturer & supplier

Chemical Name:2-oxo-1,3-dihydrobenzimidazole-5-carboxylic acid

CAS.NO:23814-14-4

Synonyms:2-Oxo-2,3-dihydro-1H-benzimidazole-5-carboxylic acid;2-Oxo-2,3-dihydro-1H-benzoimidazole-5-carboxylic acid;1H-Benzimidazole-5-carboxylic acid, 2,3-dihydro-2-oxo-;2-oxo-2,3-dihydro-1H-1,3-benzodiazole-5-carboxylic acid;2-oxo-2,3-dihydro-1H-1,3-benzimidazole-5-carboxylic acid;BEN259;2-Oxo-2,3-dihydro-1H-benzimidazol-5-carbonsaeure;2-oxo-3-hydrobenzimidazole-5-carboxylic acid;1H-Benzimidazole-5-carboxylicacid

Molecular Formula:C₈H₆N₂O₃

Molecular Weight:178.145

HS Code:2933990090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:258.6±19.0 °C at 760 mmHg

Density:1.5±0.1 g/cm3

Index of Refraction:1.637

PSA:85.95000

Exact Mass:178.037842

LogP:1.15

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-Oxo-2,3-dihydro-1H-benzimidazole-5-carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1H-Benzimidazole-5-carboxylicacid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,BEN259 Use and application,2-oxo-3-hydrobenzimidazole-5-carboxylic acid technical grade,usp/ep/jp grade.

Related News: the strategy lays out the challenges that researchers and institutions are facing, including skills shortages in particular disciplines, limited opportunities for career progression and issues of bullying and harassment. 9-fluoro-1-hydroxy-5-methyl-3-oxo-6,7-dihydro-3H,5H-pyrido[3,2,1-ij]quinoline-2-carboxylic acid 2-dimethylaminoethylamide manufacturers Dr. Elsie Melsopp, Head of Solids Formulations for Alcami, says the company successfully helped a client overcome an API supply shortage using Quality by Design (QbD) studies to successfully formulate an orphan drug product. benzoyloxy(octadecanoyloxy)aluminum,hydrate suppliers IBI321 was discovered through a collaboration between Innovent and Eli Lilly and Company and has been developed in China by Innovent. The IND for IBI321 has been approved by the NMPA in China, and clinical trials in China are actively being conducted. 1-(2-cyclohexylacetoxy)ethyl 5-fluoro-2,4-dioxo-3,4-dihydropyrimidine-1(2H)-carboxylate vendor & factory.